CIRCULATING TUMOR CELLS: POTENTIAL MARKERS OF MINIMAL RESIDUAL DISEASE IN OVARIAN CANCER? - A STUDY OF THE OVCAD CONSORTIUM

被引：0
|
作者：
Obermayr, E. [1 ]
Bednarz-Knoll, N. [2 ]
Orsetti, B. [3 ]
Weier, H. U. [4 ]
Lambrechts, S. [5 ]
Castillo-Tong, D. Cacsire [1 ]
Reinthaller, A. [1 ]
Braicu, E. [6 ]
Mahner, S. [7 ]
Sehouli, J. [6 ]
Vergote, I. [5 ]
Theillet, C. [3 ]
Zeillinger, R. [1 ]
Brandt, B. [8 ]
机构：
[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[2] Univ Medial Ctr Eppendorf, Inst Tumor Biol, Hamburg, Germany
[3] Univ Montpellier, INSERM, U1194, Montpellier, France
[4] Lawrence Berkeley Natl Lab, Life Sci, Berkeley, CA USA
[5] Leuven Canc Inst, Obstet & Gynecol, Leuven, Belgium
[6] Charite Univ Med Berlin, Gynecol, Berlin, Germany
[7] Univ Medial Ctr Eppendorf, Gynecol Gynecol Oncol, Hamburg, Germany
[8] Univ Med Ctr Schleswig Holstein, Clin Chem, Kiel, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0925
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [31] Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
    Aust, Stefanie
    Bachmayr-Heyda, Anna
    Pateisky, Petra
    Tong, Dan
    Darb-Esfahani, Silvia
    Denkert, Carsten
    Chekerov, Radoslav
    Sehouli, Jalid
    Mahner, Sven
    Van Gorp, Toon
    Vergote, Ignace
    Speiser, Paul
    Horvat, Reinhard
    Zeillinger, Robert
    Pils, Dietmar
    MOLECULAR CANCER, 2012, 11
  • [32] Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease.
    Raut, Nirmal Vivek
    Bharde, Atul
    Gourishankar, Aland
    Jayant, Sreeja
    Garbhe, Meghana
    Gosavi, Sayali
    Janorkar, Apoorva
    D'Souza, Alain
    Vasudevan, Aravindan
    Khandare, Jayant
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
    Wu, Ching-Yang
    Lee, Chia-Lin
    Wu, Ching-Feng
    Fu, Jui-Ying
    Yang, Cheng-Ta
    Wen, Chi-Tsung
    Liu, Yun-Hen
    Liu, Hui-Ping
    Hsieh, Jason Chia-Hsun
    DIAGNOSTICS, 2020, 10 (03)
  • [34] Stem-like markers in the circulating tumor cells assessment in ovarian cancer.
    Gening, Snezhanna
    Abakumova, Tatyana
    Antoneeva, Inna
    Gening, Tatyana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer
    Shu, Tong
    Liang, Yiming
    Zhang, Siwen
    Su, Tianqi
    Gao, Yunong
    Guo, Chang
    Li, Zhe
    Gao, Min
    Zhang, Nan
    Son, Nan
    Zhang, Naiyi
    Gao, Weijiao
    Wang, Wei
    Wan, Hongguo
    Cai, Yan
    Zhang, Feng
    Ji, Xuwo
    Dong, Yu
    Zhen, Hong
    GYNECOLOGIC ONCOLOGY, 2025, 192 : 94 - 101
  • [36] Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
    Stefanie Aust
    Katharina Auer
    Anna Bachmayr-Heyda
    Carsten Denkert
    Jalid Sehouli
    Ioana Braicu
    Sven Mahner
    Sandrina Lambrechts
    Ignace Vergote
    Christoph Grimm
    Reinhard Horvat
    Dan Cacsire Castillo-Tong
    Robert Zeillinger
    Dietmar Pils
    Molecular Cancer, 13
  • [37] Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer
    Chitwood, Holly
    Myers, Adria
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 369 - 374
  • [38] Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer
    Chaudhuri, Aadel
    Lovejoy, Alexander
    Chabon, Jacob
    Newman, Aaron
    Stehr, Henning
    Say, Carmen
    Carter, Justin
    Zhou, Li
    West, Robert
    Shrager, Joseph
    Neal, Joel
    Wakelee, Heather
    Loo, Billy
    Alizadeh, Ash
    Diehn, Maximilian
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S445 - S445
  • [39] CIRCULATING MUCINS AS TUMOR-MARKERS IN OVARIAN-CANCER
    DEVINE, PL
    MCGUCKIN, MA
    WARD, BG
    ANTICANCER RESEARCH, 1992, 12 (03) : 709 - 717
  • [40] Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
    P Anker
    M Stroun
    Leukemia, 2001, 15 : 289 - 291
12345